Choi Sang Won, Pangeni Rudra, Jung Dai Hyun, Kim Su Jung, Park Jin Woo
College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan-gun, Jeonnam 58554, Republic of Korea.
BIO-FD&C Co. Ltd., Hwasun-gun, Jeonnam 58141, Republic of Korea.
J Nanosci Nanotechnol. 2018 Feb 1;18(2):842-847. doi: 10.1166/jnn.2018.14864.
The exogenous administration of growth factors has been examined for treating wounds and such factors serve as cosmetic agents for skin regeneration. However, the topical application of growth factors is hampered by their limited percutaneous absorption. In this study, we genetically modified basic fibroblast growth factor (bFGF) and vascular endothelial growth factor-A (VEGF-A) using a cell-penetrating peptide to facilitate their permeation into skin and to avoid multiple steps in the chemical or physical modification of biomaterials. Low-molecular-weight protamine (LMWP)-fused bFGF and VEGF-A (LMWP-bFGF and LMWP-VEGF-A) were designed by serial polymerase chain reaction (PCR)-mediated addition of the LMWP codons onto the bFGF and VEGF-A genes and then produced in Escherichia coli. The purified LMWP-bFGF and LMWP-VEGF-A represented >90% of the total proteins, as determined by SDS-PAGE and densitometric quantification, and their actual molecular weights, determined by mass spectroscopy, were 19,026 and 15,715 Da, respectively, corresponding to the theoretical values. N-terminal amino acid sequencing analyses confirmed the N-terminal conjugation of LMWP to bFGF and VEGF-A. Immunoblotting analyses using antibodies against bFGF and VEGF-A, together with the proliferative effects of LMWP-bFGF and LMWP- VEGF-A on human keratinocytes and fibroblasts, demonstrated that the original biological activity of each growth factor was not altered by LMWP conjugation. In addition, the LMWP conjugation did not induce further cytotoxic effects on the skin cells, while the cell membrane-penetrating activities of LMWP-bFGF and LMWP-VEGF-A were significantly enhanced compared with the respective unconjugated growth factors. These results suggest that LMWP-bFGF and LMWP-VEGF-A can be used as effective topical therapeutic or cosmetic agents for skin regeneration and anti-aging treatments.
已经对生长因子的外源性给药用于治疗伤口进行了研究,并且这些因子可作为皮肤再生的美容剂。然而,生长因子的局部应用受到其经皮吸收有限的阻碍。在本研究中,我们使用细胞穿透肽对碱性成纤维细胞生长因子(bFGF)和血管内皮生长因子-A(VEGF-A)进行基因改造,以促进它们渗透到皮肤中,并避免生物材料化学或物理修饰中的多个步骤。通过连续聚合酶链反应(PCR)介导将低分子量鱼精蛋白(LMWP)密码子添加到bFGF和VEGF-A基因上,设计出融合LMWP的bFGF和VEGF-A(LMWP-bFGF和LMWP-VEGF-A),然后在大肠杆菌中产生。通过SDS-PAGE和光密度定量测定,纯化的LMWP-bFGF和LMWP-VEGF-A占总蛋白的>90%,并且通过质谱测定的它们的实际分子量分别为19,026和1,